ETA kidnapper released on cancer bail ordered to undergo medical exam
Court experts argue Bolinaga's terminal condition could be treated satisfactorily within the penitenciary system


Josu Uribetxebarria Bolinaga, a convicted ETA terrorist who was released on compassionate grounds last August, has been ordered to submit to a round of testing by High Court forensic experts.
Judge Luis Castro on Friday rejected Bolinaga's appeal against further examination on the grounds that voluntarily undergoing medical checks was one of the obligations inserted into the ruling that granted him a conditional release last year. Bolinaga was freed on the grounds that he was suffering from incurable cancer of the kidneys, brain and lungs.
A report by the Basque regional health service (Osakidetza) in July stated that Bolinaga's condition was still very serious but the High Court's forensic investigators said they believed the ETA member was at "a standstill in the oncological process." Therefore, they argued, Bolinaga's state of health "does not impede" his treatment being administered within the penitentiary system.
Through his lawyer, Bolinaga has refused to undergo the new check-up and offered to hand over the documentation provided by the Osakidetza. Castro responded that the examination was merely "to evaluate the symptoms of the patient in relation to his conditional release." Bolinaga is due to report to Donostia hospital at the end of the month for a check-up by the regional health authority.
He was jailed for 32 years for his part in the kidnapping of José Antonio Ortega Lara, a former prison director, in the late 1990s. Lara was held by ETA in dreadful conditions for 532 days.
Tu suscripción se está usando en otro dispositivo
¿Quieres añadir otro usuario a tu suscripción?
Si continúas leyendo en este dispositivo, no se podrá leer en el otro.
FlechaTu suscripción se está usando en otro dispositivo y solo puedes acceder a EL PAÍS desde un dispositivo a la vez.
Si quieres compartir tu cuenta, cambia tu suscripción a la modalidad Premium, así podrás añadir otro usuario. Cada uno accederá con su propia cuenta de email, lo que os permitirá personalizar vuestra experiencia en EL PAÍS.
¿Tienes una suscripción de empresa? Accede aquí para contratar más cuentas.
En el caso de no saber quién está usando tu cuenta, te recomendamos cambiar tu contraseña aquí.
Si decides continuar compartiendo tu cuenta, este mensaje se mostrará en tu dispositivo y en el de la otra persona que está usando tu cuenta de forma indefinida, afectando a tu experiencia de lectura. Puedes consultar aquí los términos y condiciones de la suscripción digital.
Últimas noticias
More than 40 Democratic lawmakers urge Trump in a letter to stop his ‘attempts to undermine democracy in Brazil’
The journal ‘Science’ criticizes Trump’s anti-renewable energy policy: ‘The US is failing to benefit from its own innovations’
Cubans hope for a miracle as dengue and chikungunya spread
The long shadow of the father figure in the films of Rob Reiner
Most viewed
- Christian Louboutin: ‘Young people don’t want to be like their parents. And if their parents wear sneakers, they’re going to look for something else’
- Cartels in Mexico take a leap forward with narco-drones: ‘It is criminal groups that are leading the innovation race’
- ‘El Limones’ and the growing union disguise of Mexican organized crime
- The low-cost creative revolution: How technology is making art accessible to everyone
- ‘We are dying’: Cuba sinks into a health crisis amid medicine shortages and misdiagnosis








































